Frazier Healthcare Partners announced a definitive agreement to acquire MatrixCare from Resmed. The proposed transaction is subject to customary closing conditions and is expected to close during the third quarter of 2026.
MatrixCare is a provider of cloud-based electronic health record software purpose-built for out-of-hospital care settings. The company serves skilled nursing, senior living, home health, hospice, and life plan communities.
The transaction includes MatrixCare and related software offerings historically sold under the MatrixCare brand. This includes Healthcare First, Citus, and home health and hospice solutions.
MatrixCare provides software solutions to more than 15,000 providers across skilled nursing, senior living, long-term care, life plan communities, home health, and hospice care. The company has also been recognized as a multi-year Best in KLAS award winner.
Frazier said it has spent several years evaluating the post-acute care technology sector. The firm believes MatrixCare has established itself as a leading platform serving skilled nursing, senior living, home health, and hospice providers.
Frazier plans to invest in product innovation to support MatrixCare’s next phase of growth. The firm said the goal is to help providers improve outcomes as the post-acute care landscape continues to evolve.
For Resmed, the divestiture aligns with its 2030 strategy and portfolio management approach. Terms of the deal were not disclosed.
Founded in 1991, Frazier Healthcare Partners is a private equity firm focused exclusively on the healthcare industry. Since inception, the firm has raised more than $11 billion of capital for private funds and co-investment opportunities and has invested in more than 200 companies over 35 years.
KEY QUOTES:
“Frazier has spent several years evaluating the post-acute care technology sector and believes MatrixCare has established itself as a leading platform serving skilled nursing, senior living, and home health and hospice providers.”
Ryan Lucero, General Partner at Frazier Healthcare Partners
“We are thrilled to partner with the MatrixCare team and plan to invest aggressively in product innovation to help providers deliver better outcomes as the post-acute care landscape continues to evolve.”
Clarissa Berman, Principal at Frazier Healthcare Partners
“This divestiture is aligned with Resmed’s 2030 strategy with a focused approach to portfolio management. We’re confident that Frazier Healthcare is an excellent steward for our MatrixCare team members and solutions.”
Mick Farrell, Chairman and CEO of Resmed
